VentriPoint Diagnostics Ltd. (VPTDF)
USD 0.1
(0.05%)
USD 0.1
(0.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.69 Million CAD | 19.01% |
| 2022 | 1.42 Million CAD | 17.54% |
| 2021 | 1.21 Million CAD | -61.56% |
| 2020 | 3.15 Million CAD | 13.17% |
| 2019 | 2.78 Million CAD | 93.35% |
| 2018 | 1.43 Million CAD | -56.84% |
| 2017 | 3.33 Million CAD | 14.16% |
| 2016 | 2.92 Million CAD | 19.31% |
| 2015 | 2.44 Million CAD | -15.17% |
| 2014 | 2.88 Million CAD | -25.62% |
| 2013 | 3.88 Million CAD | 1.49% |
| 2012 | 3.82 Million CAD | -19.83% |
| 2011 | 4.77 Million CAD | 86.28% |
| 2010 | 2.56 Million CAD | -26.05% |
| 2009 | 3.46 Million CAD | 53.25% |
| 2008 | 2.26 Million CAD | 278.51% |
| 2007 | 597.11 Thousand CAD | 6161.83% |
| 2006 | 9535.77 CAD | 67.67% |
| 2005 | 5687.38 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.72 Million CAD | 53.25% |
| 2024 Q1 | 1.77 Million CAD | 4.89% |
| 2023 Q2 | 1.49 Million CAD | 1.5% |
| 2023 FY | 1.69 Million CAD | 19.01% |
| 2023 Q4 | 1.69 Million CAD | 5.7% |
| 2023 Q3 | 1.6 Million CAD | 7.06% |
| 2023 Q1 | 1.47 Million CAD | 3.6% |
| 2022 Q1 | 1.07 Million CAD | -11.2% |
| 2022 Q4 | 1.42 Million CAD | 22.16% |
| 2022 Q2 | 1.26 Million CAD | 17.8% |
| 2022 Q3 | 1.16 Million CAD | -8.02% |
| 2022 FY | 1.42 Million CAD | 17.54% |
| 2021 Q2 | 1.37 Million CAD | -38.77% |
| 2021 FY | 1.21 Million CAD | -61.56% |
| 2021 Q4 | 1.21 Million CAD | -13.4% |
| 2021 Q3 | 1.39 Million CAD | 1.55% |
| 2021 Q1 | 2.24 Million CAD | -28.61% |
| 2020 Q1 | 3.19 Million CAD | 14.76% |
| 2020 Q4 | 3.15 Million CAD | -0.15% |
| 2020 Q2 | 3.44 Million CAD | 7.99% |
| 2020 FY | 3.15 Million CAD | 13.17% |
| 2020 Q3 | 3.15 Million CAD | -8.55% |
| 2019 Q3 | 2.99 Million CAD | 4.57% |
| 2019 Q4 | 2.78 Million CAD | -7.18% |
| 2019 Q1 | 2.74 Million CAD | 90.88% |
| 2019 FY | 2.78 Million CAD | 93.35% |
| 2019 Q2 | 2.86 Million CAD | 4.36% |
| 2018 Q2 | 2.08 Million CAD | -12.44% |
| 2018 Q1 | 2.37 Million CAD | -28.68% |
| 2018 Q4 | 1.43 Million CAD | 9.34% |
| 2018 FY | 1.43 Million CAD | -56.84% |
| 2018 Q3 | 1.31 Million CAD | -36.8% |
| 2017 FY | 3.33 Million CAD | 14.16% |
| 2017 Q4 | 3.33 Million CAD | 22.09% |
| 2017 Q3 | 2.73 Million CAD | -35.59% |
| 2017 Q2 | 4.24 Million CAD | -42.79% |
| 2017 Q1 | 7.41 Million CAD | 153.74% |
| 2016 Q1 | 1.83 Million CAD | -25.13% |
| 2016 FY | 2.92 Million CAD | 19.31% |
| 2016 Q4 | 2.92 Million CAD | 20.97% |
| 2016 Q3 | 2.41 Million CAD | 14.28% |
| 2016 Q2 | 2.11 Million CAD | 15.27% |
| 2015 Q1 | 3.36 Million CAD | 16.58% |
| 2015 Q2 | 3.51 Million CAD | 4.5% |
| 2015 Q3 | 3.29 Million CAD | -6.44% |
| 2015 FY | 2.44 Million CAD | -15.17% |
| 2015 Q4 | 2.44 Million CAD | -25.58% |
| 2014 Q2 | 3.52 Million CAD | -8.4% |
| 2014 Q1 | 3.84 Million CAD | -0.86% |
| 2014 FY | 2.88 Million CAD | -25.62% |
| 2014 Q4 | 2.88 Million CAD | -4.27% |
| 2014 Q3 | 3.01 Million CAD | -14.43% |
| 2013 FY | 3.88 Million CAD | 1.49% |
| 2013 Q4 | 3.88 Million CAD | -30.64% |
| 2013 Q3 | 5.59 Million CAD | 41.56% |
| 2013 Q2 | 3.95 Million CAD | 5.69% |
| 2013 Q1 | 3.74 Million CAD | -2.2% |
| 2012 FY | 3.82 Million CAD | -19.83% |
| 2012 Q4 | 3.82 Million CAD | -8.81% |
| 2012 Q1 | 3.45 Million CAD | -27.53% |
| 2012 Q3 | 4.19 Million CAD | -1.72% |
| 2012 Q2 | 4.26 Million CAD | 23.43% |
| 2011 Q2 | 4.65 Million CAD | 11.97% |
| 2011 Q4 | 4.77 Million CAD | -14.68% |
| 2011 FY | 4.77 Million CAD | 86.28% |
| 2011 Q1 | 4.16 Million CAD | 62.44% |
| 2011 Q3 | 5.59 Million CAD | 20.04% |
| 2010 Q4 | 2.56 Million CAD | -24.68% |
| 2010 Q3 | 3.4 Million CAD | 6.76% |
| 2010 FY | 2.56 Million CAD | -26.05% |
| 2010 Q2 | 3.18 Million CAD | -6.35% |
| 2010 Q1 | 3.4 Million CAD | -1.81% |
| 2009 FY | 3.46 Million CAD | 53.25% |
| 2009 Q3 | 3.24 Million CAD | 3.42% |
| 2009 Q1 | 3.19 Million CAD | 41.22% |
| 2009 Q2 | 3.13 Million CAD | -1.69% |
| 2009 Q4 | 3.46 Million CAD | 6.74% |
| 2008 Q2 | 783.4 Thousand CAD | -1.52% |
| 2008 Q3 | 995.92 Thousand CAD | 27.13% |
| 2008 FY | 2.26 Million CAD | 278.51% |
| 2008 Q4 | 2.26 Million CAD | 126.94% |
| 2008 Q1 | 795.5 Thousand CAD | 33.23% |
| 2007 FY | 597.11 Thousand CAD | 6161.83% |
| 2007 Q4 | 597.11 Thousand CAD | -39.71% |
| 2007 Q3 | 990.46 Thousand CAD | 14902.39% |
| 2007 Q2 | 6602.03 CAD | -59.77% |
| 2007 Q1 | 16.41 Thousand CAD | 72.11% |
| 2006 Q4 | 9535.77 CAD | 62.98% |
| 2006 Q3 | 5850.98 CAD | -9.38% |
| 2006 Q1 | 6107.63 CAD | 0.0% |
| 2006 FY | 9535.77 CAD | 67.67% |
| 2006 Q2 | 6456.79 CAD | 5.72% |
| 2005 FY | 5687.38 CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| IR-Med Inc. | 634 Thousand USD | -167.142% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | 89.811% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -149.947% |
| Polarean Imaging plc | 2.58 Million USD | 34.367% |
| Avitar, Inc. | 11.59 Million USD | 85.391% |
| AVITA Medical, Inc. | 19.86 Million USD | 91.474% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 20.034% |
| Össur hf. | 688.8 Million USD | 99.754% |
| Zecotek Photonics Inc. | 5.86 Million USD | 71.14% |
| QHSLab, Inc. | 2.05 Million USD | 17.665% |
| Wellstar International, Inc. | 55.99 Million USD | 96.975% |
| Össur hf. | 688.8 Million USD | 99.754% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 89.468% |
| Escalon Medical Corp. | 2.94 Million USD | 42.555% |
| Aurora Spine Corporation | 6.65 Million USD | 74.545% |
| BrainsWay Ltd. | 15.31 Million USD | 88.94% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 71.831% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 96.305% |
| Vivos Inc. | 245 Thousand USD | -591.286% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.932% |
| Kelyniam Global, Inc. | 1.01 Million USD | -67.205% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -514.511% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 30.865% |
| Nanomix Corporation | 14.81 Million USD | 88.568% |
| Theraclion SA | 13.01 Million EUR | 86.988% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 66.947% |
| Positron Corporation | 2.02 Million USD | 16.403% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 53.228% |
| Lombard Medical, Inc. | 53.79 Million USD | 96.852% |
| ALR Technologies Inc. | 24.5 Million USD | 93.089% |
| Stratec SE | 271.97 Million USD | 99.377% |
| Vycor Medical, Inc. | 4.31 Million USD | 60.774% |
| Heart Tronics, Inc. | 1.09 Million USD | -54.704% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 28.197% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 69.074% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 97.418% |
| VMS Rehab Systems, Inc. | 201.36 USD | -841019.885% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 69.065% |
| Ingen Technologies, Inc. | 5.7 Million USD | 70.336% |
| Odyssey Group International, Inc. | 6.61 Million USD | 74.384% |
| United American Healthcare Corporation | 119 Thousand USD | -1323.26% |
| ECGI Holdings, Inc. | 11.94 Million USD | 85.816% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -27.923% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -17.101% |
| Urologix, Inc. | 12.64 Million USD | 86.605% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 68.613% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 80.033% |
| SS Innovations International, Inc. | 11.18 Million USD | 84.852% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -222.368% |
| Smith & Nephew plc | 4.76 Billion USD | 99.964% |
| NIOX Group Plc | 9.8 Million USD | 82.721% |
| Fuse Medical, Inc. | 15.11 Million USD | 88.791% |
| Broncus Holding Corporation | 10.43 Million USD | 83.765% |
| Brain Scientific Inc. | 7.42 Million USD | 77.194% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 94.99% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -113.288% |